Page 141 - REV T-I JOURNAL INTERIOR ISSUU 18 2-3
P. 141

Technology and Innovation, Vol. 18, pp. 217-218, 2016             ISSN 1949-8241  • E-ISSN 1949-825X
          Printed in the USA. All rights reserved.                      http://dx.doi.org/10.21300/18.2-3.2016.217
          Copyright © 2016 National Academy of Inventors.                    www.technologyandinnovation.org







                                      TAKING AIM AT CANCER



                                       James Higgins and Alex Camarota
                    Office of Innovation Development, United States Patent and Trademark Office, Alexandria, VA, USA


                      In his final State of the Union Address, President Obama announced the “Cancer Moonshot,”
                      an effort to greatly accelerate the rate of progress in cancer treatment development over the
                      next five years. To support this effort, the USPTO is launching several initiatives that leverage
                      the role patents play in catalyzing life-saving medical treatments.

                      Key words: Patents; Innovation; Immunotherapy; Cancer; Cancer moonshot; USPTO





            Fostering American innovation has always been   for this goal to be realized. The USPTO has a partic-
          a central mission of the United States Patent and   ular call to action in this “moonshot moment.” The
          Trademark Office (USPTO), inseparable from our   president’s plan leverages the USPTO’s mission as an
          role in protecting it. Although the process for receiving   important catalyst for research and development by
          that protection in the form of a patent can be lengthy,   freeing trapped data, resolving applications that are
          the USPTO strives to ensure that it is thorough and   without a final decision, and increasing patient access
          fair. Patents must be issued while the technology is   to treatment and clinical studies. The goal is to halve
          still relevant in order to provide a benefit in the mar-  the average examination time of patents pertaining to
          ketplace. The patenting process has been especially   certain medical technologies and thereby reduce the
          critical in the medical field, as it protects and mone-  time it takes for that technology to reach a patient. To
          tizes the investment in research and development that   meet the president’s expectations, we must also tap
          is poured into life-saving technologies. Indeed, the   into the resources of several different agencies. The
          patent system has spurred life-changing technological   USPTO will launch two new programs to accomplish
          innovation around the world.                  these tasks.
            In that same spirit of progress and improvement,     First, the USPTO established a “Fast Track” review
          President Obama used his final State of the Union   pilot program for certain treatment-related patents
          address to challenge the United States to make ten   in order for medicines and technologies to reach
          years’ worth of progress toward finding a cure for can-  patients more quickly. This pilot program, “Patents 4
          cer in just five. Federal and state agencies, nonprofits,   Patients,” more formally known as the “Cancer Immu-
          businesses, and citizens must collectively contribute   notherapy Pilot Program,” will cut the time it takes to

          _____________________
          Accepted July 1, 2016.
          Address correspondence to: Alex Camarota, Office of Innovation Development, U.S. Patent and Trademark Office, 600 Dulany Street, Alexandria, VA 22314,
          USA. E-mail: alexander.camarota@uspto.gov



                                                    217
   136   137   138   139   140   141   142   143   144   145   146